Chalk up one more biotech start­up for MIT’s Bob Langer

Bob Langer has an­oth­er biotech start­up to add to his lengthy ros­ter.

Lyn­dra has gath­ered $23 mil­lion to­geth­er to work on a new de­liv­ery tech plat­form de­vel­oped by Langer, Gio­van­ni Tra­ver­so and An­drew Bellinger at MIT.

Lyn­dra’s big idea is that it can de­vel­op plat­form tech that can pro­vide “ul­tra” long act­ing sus­tained re­lease of oral drugs. And it says this new ap­proach could al­so re­duce the side ef­fects as­so­ci­at­ed with some drugs while vast­ly im­prov­ing com­pli­ance. Po­laris part­ner and co-founder Amy Schul­man is lead­ing the ef­fort.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER